Ewing Sarcoma — Trials

Ewing Sarcoma — Trials · CancerIndex

Clinical trials

Registered studies

217 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 76
Recruiting: 41
Ph III recruiting: 1
Growth YoY: —
Industry share: 17%
Top sponsor: National Cancer Institute (NCI)
Termination share: 32.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (30)

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04791228	A Pilot Study of Thermodox and MR-HIFU for Treatment of Relapsed Solid Tumors	withdrawn	Phase 2	0	Children's National Research InstituteOTHER	1	Jan 1, 2025	clinicaltrials
NCT05042934	Lurbinectedin With or Without Irinotecan in Treating Patients With Relapsed or High Risk Metastatic Ewing Sarcoma	withdrawn	Phase 1 / Phase 2	0	M.D. Anderson Cancer CenterOTHER	1	Feb 10, 2022	clinicaltrials